Connection

Nichole Tanner to Female

Back to Details
This is a "connection" page, showing publications Nichole Tanner has written about Female.
Nichole Tanner
Connection Strength
0.726
Female
  1. An Evaluation of Annual Adherence to Lung Cancer Screening in a Large National Cohort. Am J Prev Med. 2022 08; 63(2):e59-e64.
    View in: PubMed
    Score: 0.043
  2. Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2021 03; 159(3):1283-1287.
    View in: PubMed
    Score: 0.039
  3. Association of Cigarette Type and Nicotine Dependence in Patients Presenting for Lung Cancer Screening. Chest. 2020 11; 158(5):2184-2191.
    View in: PubMed
    Score: 0.038
  4. Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project. Chest. 2020 10; 158(4):1742-1752.
    View in: PubMed
    Score: 0.037
  5. Association of Cigarette Type With Lung Cancer Incidence and Mortality: Secondary Analysis of the National Lung Screening Trial. JAMA Intern Med. 2019 12 01; 179(12):1710-1712.
    View in: PubMed
    Score: 0.036
  6. Effect of a Rule-in Biomarker Test on Pulmonary Nodule Management: A Survey of Pulmonologists and Thoracic Surgeons. Clin Lung Cancer. 2020 03; 21(2):e89-e98.
    View in: PubMed
    Score: 0.035
  7. Standard Bronchoscopy With Fluoroscopy vs Thin Bronchoscopy and Radial Endobronchial Ultrasound for Biopsy of Pulmonary Lesions: A Multicenter, Prospective, Randomized Trial. Chest. 2018 11; 154(5):1035-1043.
    View in: PubMed
    Score: 0.033
  8. Reviewing Lung Cancer Screening: The Who, Where, When, Why, and How. Clin Chest Med. 2018 03; 39(1):31-43.
    View in: PubMed
    Score: 0.032
  9. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease. Am J Respir Crit Care Med. 2017 09 01; 196(5):602-608.
    View in: PubMed
    Score: 0.031
  10. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270.
    View in: PubMed
    Score: 0.030
  11. Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study. Ann Am Thorac Soc. 2016 11; 13(11):1977-1982.
    View in: PubMed
    Score: 0.029
  12. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016 Mar 01; 193(5):534-41.
    View in: PubMed
    Score: 0.028
  13. Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414.
    View in: PubMed
    Score: 0.028
  14. What's in a Number? When It Comes to Pulmonary Nodules, It's All About the Number. Am J Respir Crit Care Med. 2015 Nov 15; 192(10):1149-50.
    View in: PubMed
    Score: 0.027
  15. Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. Am J Respir Crit Care Med. 2015 Jul 15; 192(2):200-8.
    View in: PubMed
    Score: 0.027
  16. Attitudes and beliefs toward lung cancer screening among US Veterans. Chest. 2013 Dec; 144(6):1783-1787.
    View in: PubMed
    Score: 0.024
  17. Simultaneously diagnosing and staging lung cancer: a win-win for the patient and the health-care system. Chest. 2013 Dec; 144(6):1747-1749.
    View in: PubMed
    Score: 0.024
  18. Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. J Thorac Oncol. 2012 Feb; 7(2):365-9.
    View in: PubMed
    Score: 0.021
  19. Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study. Ann Intern Med. 2022 Nov; 175(11):1501-1505.
    View in: PubMed
    Score: 0.011
  20. Factors Associated With Smoking Cessation Attempts in Lung Cancer Screening: A Secondary Analysis of the National Lung Screening Trial. Chest. 2023 02; 163(2):433-443.
    View in: PubMed
    Score: 0.011
  21. Occurrence of Discussion about Lung Cancer Screening Between Patients and Healthcare Providers in the USA, 2017. J Cancer Educ. 2020 08; 35(4):678-681.
    View in: PubMed
    Score: 0.010
  22. An Evaluation of Diagnostic Yield From Bronchoscopy: The Impact of Clinical/Radiographic Factors, Procedure Type, and Degree of Suspicion for Cancer. Chest. 2020 06; 157(6):1656-1664.
    View in: PubMed
    Score: 0.009
  23. Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for?Moderate Sedation During Bronchoscopy. Chest. 2019 01; 155(1):137-146.
    View in: PubMed
    Score: 0.008
  24. Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2018 07 15; 198(2):e3-e13.
    View in: PubMed
    Score: 0.008
  25. Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial. Chest. 2018 07; 154(1):110-118.
    View in: PubMed
    Score: 0.008
  26. Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2018 09; 154(3):491-500.
    View in: PubMed
    Score: 0.008
  27. Comparing Pulmonary Nodule Location During Electromagnetic Bronchoscopy With Predicted Location on the Basis of Two Virtual Airway Maps at Different Phases of?Respiration. Chest. 2018 01; 153(1):181-186.
    View in: PubMed
    Score: 0.008
  28. Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival. Chest. 2017 09; 152(3):587-597.
    View in: PubMed
    Score: 0.008
  29. Implementation of Lung Cancer Screening in the Veterans Health Administration. JAMA Intern Med. 2017 03 01; 177(3):399-406.
    View in: PubMed
    Score: 0.007
  30. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74.
    View in: PubMed
    Score: 0.007
  31. Reply: Lung Cancer Screening: The Balance between Harm and Benefit. Am J Respir Crit Care Med. 2015 May 15; 191(10):1209-10.
    View in: PubMed
    Score: 0.007
  32. Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33.
    View in: PubMed
    Score: 0.006
  33. Factors that influence physician decision making for indeterminate pulmonary nodules. Ann Am Thorac Soc. 2014 Dec; 11(10):1586-91.
    View in: PubMed
    Score: 0.006
  34. Outcome of patients with negative and unsatisfactory cytologic specimens obtained by endobronchial ultrasound-guided transbronchial fine-needle aspiration of mediastinal lymph nodes. Cancer Cytopathol. 2015 Feb; 123(2):92-7.
    View in: PubMed
    Score: 0.006
  35. Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 2014 Aug; 146(2):406-411.
    View in: PubMed
    Score: 0.006
  36. Response. Chest. 2014 Aug; 146(2):e70.
    View in: PubMed
    Score: 0.006
  37. The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest. 2014 Mar 01; 145(3):464-472.
    View in: PubMed
    Score: 0.006
  38. The use of convex probe endobronchial ultrasound-guided transbronchial needle aspiration in a pediatric population: a multicenter study. Pediatr Pulmonol. 2014 Aug; 49(8):807-15.
    View in: PubMed
    Score: 0.006
  39. Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest. 2011 Dec; 140(6):1550-1556.
    View in: PubMed
    Score: 0.005
  40. A 79-year-old woman with a right paratracheal mass. Chest. 2009 May; 135(5):1384-1388.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.